| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MLN4924 | GDSC1000 | pan-cancer | AAC | -0.16 | 9e-05 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0001 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | -0.15 | 0.0001 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | -0.15 | 0.0001 |
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0001 |
| mRNA | phloretin | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0001 |
| mRNA | BRD-K66453893 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0001 |
| mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0002 |
| mRNA | ZG-10 | GDSC1000 | pan-cancer | AAC | -0.17 | 0.0002 |
| mRNA | FQI-1 | CTRPv2 | pan-cancer | AAC | -0.18 | 0.0002 |